Second round of radiation for tumors that come back
Part of Cancer clinical trials.
This study tests a new way to plan a second course of radiation for cancer that has returned or spread to a few places. It uses special imaging software to make the treatment more precise and aims to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be getting radiation again with the goal of curing the cancer.
- The new radiation area must overlap with where you had radiation before.
- You should have less than 5 tumors in no more than 3 different areas, or a cancer that came back in one spot, or a second new cancer.
- You need to be expected to live more than 6 months.
- You must not have cancer in the brain, prostate, rectum, or esophagus that needs re-radiation.
- You must be able to stop certain medications (like targeted pills) if needed during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a second round of precise, high-dose radiation (stereotactic body radiotherapy) for men whose prostate cancer has come back only in the prostate after their first radiation treatment. It aims to control the recurrence with fewer side effects.
This trial compares three treatment options for breast cancer that has come back in the chest or lymph nodes after previous radiation. It looks at adding hyperthermia (heating the tumor area) to re-irradiation, versus just re-irradiation or surgery alone, to see which offers better quality of life and survival with fewer side effects.
This trial studies giving a second course of radiation to people whose cancer has come back or spread. It aims to see if more radiation can help control the cancer and improve quality of life.
This study tests whether giving a second course of radiation to the chest (called retreatment) can control lung cancer that has come back or a new cancer that started there. People who have already had radiation to their chest and are healthy enough for more may be eligible.
This trial tests whether giving a second course of radiation therapy (called reirradiation) can safely treat lung cancer that has returned after earlier radiation. The goal is to control the cancer in the chest and see how well patients do with this repeat treatment.
This study tests a more personalized way to plan “re-irradiation,” meaning giving radiation again in an area that was already treated before. It aims to better calculate organ risk to reduce harmful side effects while treating cancer.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.